Molcer (Docusate Sodium)

Docusate Sodium, the active ingredient in Molcer, is a surfactant laxative presented as a standard formulation for auricular use. It treats constipation in adults and children by softening stool and facilitating passage.

GNH USA supplies Molcer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Molcer (docusate sodium) is used as a surfactant laxative to relieve constipation.

- Constipation: softens stool and promotes easier bowel movements. - Pediatric constipation: provides stool softening for children who experience difficulty passing stool.

Common Side Effects: - Abdominal cramping: mild discomfort in the lower abdomen. - Diarrhea: loose stools occurring after administration. - Nausea: feeling of sickness or urge to vomit. - Flatulence: increased gas production. - Throat irritation: mild irritation if the product contacts the throat.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: intense pain that may indicate obstruction. - Rectal bleeding: presence of blood in stool. - Electrolyte imbalance: rare disturbance of sodium or potassium levels. - Persistent diarrhea: prolonged watery stools leading to dehydration.

Before using Molcer, consider the following precautions: - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Renal impairment: use with caution in patients with reduced kidney function. - Drug interactions: review concomitant medications for possible interactions. - Allergies: avoid if known hypersensitivity to docusate sodium or excipients. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Potential drug interactions should be evaluated prior to therapy.

Major Interactions (Avoid): - Mineral oil: may reduce the effectiveness of docusate sodium. - Antacids containing magnesium or aluminum: can interfere with stool softening.

Moderate Interactions (Monitor Closely): - Fat‑soluble vitamins (A, D, E, K): prolonged use may affect absorption. - Cholestyramine: may decrease the efficacy of docusate sodium. - Certain antibiotics (e.g., tetracycline): monitor for altered bowel habits.